The researchers looked at what barriers may be contributing to low screening rates among women in Pima County in Southern Arizona.
More research is needed to better understand how to optimize the utility of survivorship care plans in patients with breast cancer.
The ROW risk calculator makes its predictions based on age, comorbidities, functional status, tumor characteristics, and use of radiotherapy.
Researchers analyzed the association between baseline metabolic syndrome components and survival outcomes in women diagnosed with TNBC.
Quality of life in patients receiving netupitant/palonosetron chemotherapy induced nausea and vomiting.
Although most cases of lymphedema are mild or moderate, obesity and overweight are common factors in women who experience severe lymphedema and HADS-anxiety after breast cancer surgery.
A review of the Pennsylvania Medical Marijuana Program defined the symptom profile of patients with breast cancer who sought to use medical marijuana.
More patients living with metastatic breast cancer reportedly would be willing to participate in clinical trials if some changes were made.
Exploratory subgroup analyses suggest patients with triple-negative breast cancer or PDL1-positive tumors may benefit from maintenance durvalumab.
A fixed-dose combination of subcutaneous pertuzumab and trastuzumab was found to be noninferior for patients with HER2-positive breast cancer.